Streetbeat News

Stock Prices

PRAX

Praxis Precision Medicine (NASDAQ:PRAX) reported Q4 earnings, beating estimates with an EPS of $-2.97 against the expected $-3.13. Revenue increased by $515 thousand year-over-year. Despite beating last quarter's EPS estimates, the share price dropped by 5.0% the following day.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 9:55 pm

DXCM

DexCom's stock is trading higher following the announcement of FDA clearance for its product, Stelo. This regulatory approval marks a significant milestone for DexCom, potentially enhancing its market position and product portfolio.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:52 pm

ELEV

Elevation Oncology, Inc. (NASDAQ:ELEV) announced its plans to present preclinical proof-of-concept data for its HER3-targeting antibody-drug conjugate (ADC) program at the AACR Annual Meeting 2024. The data supports the ongoing development of the ADC program targeting HER3-expressing cancers, with the company on track to nominate a development candidate in 2024. The presentation aims to highlight the therapeutic potential of the HER3-ADC for treating a range of solid tumors associated with poor clinical outcomes.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:52 pm

APEI

American Public Education anticipates Q1 consolidated revenue between $151M-$153M, surpassing the estimated $150.6M. However, it expects a loss per share of $(0.25)-$(0.17), contrary to the estimated earnings of $0.04 per share.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:51 pm

MTB

M&T Bank Corp reported a decrease in average total deposits by $1.3B to $163.4B for the quarter to date, mainly due to lower brokered deposits. Additionally, the bank has paused share repurchases during Q1 2024, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:50 pm

LXU

LSB Industries (NYSE:LXU) reported a Q4 2023 GAAP EPS of $(0.07), missing the $0.05 estimate, while sales of $132.61M exceeded the $127.21M estimate. This represents a 43.24% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:46 pm

BOX

MSFT

Box Inc (NYSE:BOX) reported Q4 earnings with a slight revenue miss and an EPS beat, alongside an expanded AI partnership with Microsoft (NASDAQ:MSFT), driving its shares up in after-hours trading. Q4 revenue was $262.88 million, slightly below estimates, while EPS was 42 cents, above expectations. The company saw a 2% year-over-year revenue increase and a 6% increase in billings. Box anticipates Q1 revenue to be slightly above estimates and provided a fiscal-year 2025 revenue forecast slightly below expectations. The partnership with Microsoft aims to integrate Box AI with Microsoft Azure OpenAI Service, enhancing Box's AI capabilities for Enterprise Plus plan customers.

Portfolio Pulse from Adam Eckert

March 05, 2024 | 9:45 pm

MLNK

MeridianLink has projected its FY24 revenue to be between $313.0M and $323.0M, which is below the estimated $329.197M.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:45 pm

MEC

Mayville Engineering (NYSE:MEC) reported Q4 earnings with an EPS of $0.21, beating estimates by 62.0% against an expected $0.13. Revenue increased by $20.05 million from the same period last year. In the previous quarter, MEC missed EPS estimates by $0.01, leading to a 3.0% share price drop the following day.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 9:45 pm

EVC

Entravision Comms (NYSE:EVC) reported Q4 earnings with an EPS of $-0.21, missing estimates by -400.0% against an expected $0.07. Revenue increased by $23.73 million from the same period last year. Despite missing EPS estimates last quarter, the share price increased by 8.0% the following day. Historical performance shows mixed results in meeting EPS estimates over the past year.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 9:45 pm